Xenetic Biosciences (XBIO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Xenetic Biosciences (XBIO) is Neutral.

The composite score behind that read is -0.13, weighing +0.08 of bullish evidence against -0.27 bearish.

Xenetic Biosciences last closed at $2.13, +0.47% on the session.

Against the IVW growth benchmark the position is -0.33% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for XBIO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Xenetic Biosciences in the 20th percentile on return on equity, where 100 is best.

Xenetic Biosciences is classified under Health Care / Biotechnology, with a market capitalisation of $4.97M.

StockMap tracks Xenetic Biosciences as the 372nd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Xenetic Biosciences ranks 272nd of 381 in the group, against a group median of -0.08.